Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Tetracycline Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Dutasteride Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Eltrombopag Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Conivaptan HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Paliperidone Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Ergotamine Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
Dihydroergotamine Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020 Aug/12/2020 0
RBD mRNA Potential treatment - pre-clinical evidence Experimental Vaccine Aug/05/2020 Aug/12/2020 0